share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga Real-time News ·  Sep 21, 2022 08:16

Gainers

  • Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.
  • Biolase (NASDAQ:BIOL) stock increased by 10.26% to $2.9. The market value of their outstanding shares is at $23.9 million.
  • Ainos (NASDAQ:AIMD) shares rose 9.25% to $1.77. The company's market cap stands at $34.4 million.
  • Aytu BioPharma (NASDAQ:AYTU) stock rose 9.22% to $0.22. The company's market cap stands at $13.6 million.
  • Kiora Pharmaceuticals (NASDAQ:KPRX) stock increased by 7.67% to $0.19. The company's market cap stands at $7.1 million.
  • Clene (NASDAQ:CLNN) shares increased by 7.61% to $3.25. The market value of their outstanding shares is at $206.3 million.

Losers

  • Catalyst Biosciences (NASDAQ:CBIO) shares decreased by 71.8% to $0.55 during Wednesday's pre-market session. The market value of their outstanding shares is at $17.2 million.
  • Adamis Pharmaceuticals (NASDAQ:ADMP) shares fell 44.65% to $0.2. The market value of their outstanding shares is at $29.8 million.
  • NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock fell 14.87% to $17.7. The company's market cap stands at $15.9 million.
  • Autolus Therapeutics (NASDAQ:AUTL) shares decreased by 9.78% to $2.03. The market value of their outstanding shares is at $184.5 million.
  • Moleculin Biotech (NASDAQ:MBRX) stock declined by 9.68% to $1.12. The company's market cap stands at $32.0 million.
  • Tenax Therapeutics (NASDAQ:TENX) stock decreased by 9.0% to $0.17. The market value of their outstanding shares is at $4.3 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment